[HTML][HTML] Mesoporous silica nanoparticles for therapeutic/diagnostic applications
Based on unique intrinsic properties of mesoporous silica nanoparticles (MSNs) such as
high surface area, large pore size, good biocompatibility and biodegradability, stable …
high surface area, large pore size, good biocompatibility and biodegradability, stable …
Colorimetric sensor array based on gold nanoparticles: Design principles and recent advances
J Sun, Y Lu, L He, J Pang, F Yang, Y Liu - TrAC Trends in Analytical …, 2020 - Elsevier
A sensor array based on the pattern recognition strategy is good at distinguishing subtle
changes of extremely similar mixtures over a wide range of analyte types. Particularly …
changes of extremely similar mixtures over a wide range of analyte types. Particularly …
Molecular mechanisms of neuroinflammation in aging and Alzheimer's disease progression
FL Andronie-Cioara, AI Ardelean… - International journal of …, 2023 - mdpi.com
Aging is the most prominent risk factor for late-onset Alzheimer's disease. Aging associates
with a chronic inflammatory state both in the periphery and in the central nervous system, the …
with a chronic inflammatory state both in the periphery and in the central nervous system, the …
Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation
Curcumin is a multitherapeutic agent with great therapeutic potential in central nervous
system (CNS) diseases. In the current study, curcumin was encapsulated in solid lipid …
system (CNS) diseases. In the current study, curcumin was encapsulated in solid lipid …
The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer's disease: therapeutic implications and future …
MC Jurcău, FL Andronie-Cioara, A Jurcău, F Marcu… - Antioxidants, 2022 - mdpi.com
Alzheimer's disease (AD), the most common form of dementia, has increasing incidence,
increasing mortality rates, and poses a huge burden on healthcare. None of the currently …
increasing mortality rates, and poses a huge burden on healthcare. None of the currently …
Gold nanoparticles contact with cancer cell: A brief update
The fine-tuning of the physicochemical properties of gold nanoparticles has facilitated the
rapid development of multifunctional gold-based nanomaterials with diagnostic, therapeutic …
rapid development of multifunctional gold-based nanomaterials with diagnostic, therapeutic …
Self-therapeutic nanomaterials: Applications in biology and medicine
Over past decades, nanotechnology has contributed to the biomedical field in areas
including detection, diagnosis, and drug delivery via opto-electronic properties or …
including detection, diagnosis, and drug delivery via opto-electronic properties or …
[HTML][HTML] The roles of gold nanoparticles in the detection of amyloid-β peptide for Alzheimer's disease
J Zhao, N Xu, X Yang, G Ling, P Zhang - Colloid and Interface Science …, 2022 - Elsevier
As the most common form of dementia in humans, Alzheimer's disease (AD) is linked to
misfolding and aggregation of amyloid-β (Aβ) peptides. Gold nanoparticles (AuNPs) can …
misfolding and aggregation of amyloid-β (Aβ) peptides. Gold nanoparticles (AuNPs) can …
Formation of a protein corona influences the biological identity of nanomaterials
D Nierenberg, AR Khaled… - Reports of Practical …, 2018 - journals.viamedica.pl
The development and testing of nanomaterials is an area of interest due to promising
diagnostic and therapeutic applications in the treatment of diseases like cancer or …
diagnostic and therapeutic applications in the treatment of diseases like cancer or …
Label-free detection of β-amyloid peptides (Aβ40 and Aβ42): a colorimetric sensor array for plasma monitoring of Alzheimer's disease
Monitoring the ratio of 40-and 42-residue amyloid β peptides (ie, Aβ40 and Aβ42) in human
plasma is considered one of the hallmarks of detection of the early stage of Alzheimer's …
plasma is considered one of the hallmarks of detection of the early stage of Alzheimer's …